Literature DB >> 18783459

The effectiveness of covering smoking cessation services for medicare beneficiaries.

Geoffrey F Joyce1, Raymond Niaura, Margaret Maglione, Jennifer Mongoven, Carrie Larson-Rotter, James Coan, Pauline Lapin, Sally Morton.   

Abstract

OBJECTIVE: To examine whether reimbursement for Provider Counseling, Pharmacotherapies, and a telephone Quitline increase smoking cessation relative to Usual Care. STUDY
DESIGN: Randomized comparison trial testing the effectiveness of four smoking cessation benefits.
SETTING: Seven states that best represented the national population in terms of the proportion of those > or = 65 years of age and smoking rate. PARTICIPANTS: There were 7,354 seniors voluntarily enrolled in the Medicare Stop Smoking Program and they were followed-up for 12 months. INTERVENTION(S): (1) Usual Care, (2) reimbursement for Provider Counseling, (3) reimbursement for Provider Counseling with Pharmacotherapy, and (4) telephone counseling Quitline with nicotine patch. MAIN OUTCOME MEASURE: Seven-day self-reported cessation at 6- and 12-month follow-ups. PRINCIPAL
FINDINGS: Unadjusted quit rates assuming missing data=smoking were 10.2 percent (9.0-11.5), 14.1 percent (11.7-16.5), 15.8 percent (14.4-17.2), and 19.3 percent (17.4-21.2) at 12 months for the Usual Care, Provider Counseling, Provider Counseling + Pharmacotherapy, and Quitline arms, respectively. Results were robust to sociodemographics, smoking history, motivation, health status, and survey nonresponse. The additional cost per quitter (relative to Usual Care) ranged from several hundred dollars to $6,450.
CONCLUSIONS: A telephone Quitline in conjunction with low-cost Pharmacotherapy was the most effective means of reducing smoking in the elderly.

Entities:  

Mesh:

Year:  2008        PMID: 18783459      PMCID: PMC2614005          DOI: 10.1111/j.1475-6773.2008.00891.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  14 in total

Review 1.  Cigarette smoking among the elderly: disease consequences and the benefits of cessation.

Authors:  D M Burns
Journal:  Am J Health Promot       Date:  2000 Jul-Aug

2.  Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome.

Authors:  S M Hall; K L Delucchi; W F Velicer; C W Kahler; J Ranger-Moore; D Hedeker; J Y Tsoh; R Niaura
Journal:  Nicotine Tob Res       Date:  2001-08       Impact factor: 4.244

3.  Smoking cessation: progress, priorities, and prospectus.

Authors:  Raymond Niaura; David B Abrams
Journal:  J Consult Clin Psychol       Date:  2002-06

Review 4.  Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage.

Authors:  K E Warner
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

5.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Authors:  D E Jorenby; S J Leischow; M A Nides; S I Rennard; J A Johnston; A R Hughes; S S Smith; M L Muramoto; D M Daughton; K Doan; M C Fiore; T B Baker
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

6.  Physicians counseling smokers. A population-based survey of patients' perceptions of health care provider-delivered smoking cessation interventions.

Authors:  M G Goldstein; R Niaura; C Willey-Lessne; J DePue; C Eaton; W Rakowski; C Dubé
Journal:  Arch Intern Med       Date:  1997-06-23

Review 7.  Cigarette smoking. Health effects and cessation strategies.

Authors:  D P Sachs
Journal:  Clin Geriatr Med       Date:  1986-05       Impact factor: 3.076

8.  Measures of abstinence in clinical trials: issues and recommendations.

Authors:  John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

9.  Tobacco-control policies in 11 leading managed care organizations: progress and challenges.

Authors:  Nancy A Rigotti; Virginia P Quinn; Victor J Stevens; Leif I Solberg; Jack F Hollis; Abby C Rosenthal; Jane G Zapka; Eric France; Nancy Gordon; Sabina Smith; Mina Monroe
Journal:  Eff Clin Pract       Date:  2002 May-Jun

10.  Cigarette smoking cessation and extracranial carotid atherosclerosis.

Authors:  G S Tell; G Howard; W M McKinney; J F Toole
Journal:  JAMA       Date:  1989-02-24       Impact factor: 56.272

View more
  17 in total

1.  Smoking cessation quitlines: an underrecognized intervention success story.

Authors:  Edward Lichtenstein; Shu-Hong Zhu; Gary J Tedeschi
Journal:  Am Psychol       Date:  2010 May-Jun

Review 2.  Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence.

Authors:  Philip B Cawkwell; Caroline Blaum; Scott E Sherman
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

3.  Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.

Authors:  Kathryn L Taylor; Charlotte J Hagerman; George Luta; Paula G Bellini; Cassandra Stanton; David B Abrams; Jenna A Kramer; Eric Anderson; Shawn Regis; Andrea McKee; Brady McKee; Ray Niaura; Harry Harper; Michael Ramsaier
Journal:  Lung Cancer       Date:  2017-02-15       Impact factor: 5.705

4.  Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.

Authors:  Kathryn L Taylor; Danielle E Deros; Shelby Fallon; Jennifer Stephens; Emily Kim; Tania Lobo; Kimberly M Davis; George Luta; Jinani Jayasekera; Rafael Meza; Cassandra A Stanton; Raymond S Niaura; David B Abrams; Brady McKee; Judith Howell; Michael Ramsaier; Juan Batlle; Ellen Dornelas; Vicky Parikh; Eric Anderson
Journal:  Contemp Clin Trials       Date:  2019-05-23       Impact factor: 2.226

5.  Biopsychosocial characteristics of community-dwelling older adults with limited ability to walk one-quarter of a mile.

Authors:  Susan E Hardy; David J McGurl; Stephanie A Studenski; Howard B Degenholtz
Journal:  J Am Geriatr Soc       Date:  2010-02-22       Impact factor: 5.562

6.  The 3 Buckets of Prevention.

Authors:  John Auerbach
Journal:  J Public Health Manag Pract       Date:  2016 May-Jun

7.  A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Authors:  James G Xenakis; Elizabeth T Kinter; K Jack Ishak; Alexandra J Ward; Jeno P Marton; Richard J Willke; Simon Davies; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981

Review 8.  Smoking cessation interventions for adults aged 50 or older: A systematic review and meta-analysis.

Authors:  Danhong Chen; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2015-06-09       Impact factor: 4.492

9.  Risk perceptions among participants undergoing lung cancer screening: baseline results from the National Lung Screening Trial.

Authors:  Elyse R Park; Jamie S Ostroff; William Rakowski; Ilana F Gareen; Michael A Diefenbach; Sandra Feibelmann; Nancy A Rigotti
Journal:  Ann Behav Med       Date:  2009-08-27

10.  Trends in Use of Medications for Smoking Cessation in Medicare, 2007-2012.

Authors:  Marian Jarlenski; Seo Hyon Baik; Yuting Zhang
Journal:  Am J Prev Med       Date:  2016-03-30       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.